Clinical predictors of benefit from fulvestrant in advanced breast cancer: A meta-analysis of randomized controlled trials

被引：0
|
作者：
Niraula, S.
Pitz, M.
Gordon, V.
Grenier, D.
Amir, E.
Brandes, L.
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON M5S 1A1, Canada
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-14-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-14-02
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials
    Wen-Zhao Lin
    Qi-Ni Xu
    Hong-Biao Wang
    Xu-Yuan Li
    Breast Cancer, 2017, 24 : 345 - 352
  • [22] Metformin and survival of women with breast cancer: A meta-analysis of randomized controlled trials
    Wang, Qiandan
    Ma, Xiufen
    Long, Jianping
    Du, Xiaoyan
    Pan, Bin
    Mao, Hongyan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (03) : 263 - 269
  • [23] Compression Therapy for the Patients With Breast Cancer A Meta-analysis of Randomized Controlled Trials
    Li, Jia-Xin
    Gao, Jie
    Song, Jiang-Yan
    Li, Hui-Ping
    Yang, Wen-Juan
    Tong, Dong-Tong
    Zou, Yang
    CANCER NURSING, 2022, 45 (04) : E736 - E745
  • [24] Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
    Mastrantoni, Luca
    Garufi, Giovanna
    Di Monte, Elena
    Maliziola, Noemi
    Pasqualoni, Mariangela
    Pontolillo, Letizia
    Pannunzio, Sergio
    Cannizzaro, Maria Chiara
    Di Bello, Armando
    Fabi, Alessandra
    Palazzo, Antonella
    Tortora, Giampaolo
    Bria, Emilio
    Orlandi, Armando
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [25] Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
    Minoru Miyashita
    Masaya Hattori
    Toshimi Takano
    Tatsuya Toyama
    Hiroji Iwata
    Breast Cancer, 2020, 27 : 347 - 354
  • [26] Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
    Miyashita, Minoru
    Hattori, Masaya
    Takano, Toshimi
    Toyama, Tatsuya
    Iwata, Hiroji
    BREAST CANCER, 2020, 27 (03) : 347 - 354
  • [27] Fulvestrant for advanced breast cancer: A meta-analysis.
    Al Mubarak, Mustafa Mohammed
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Efficacy of niraparib in patients with advanced ovarian cancer: A meta-analysis of randomized controlled trials
    Marinho, Alice
    Fossen, Eduardo Lambert
    Caldeira de Freitas, Maria Carolina
    Itaya, Gabriela Coelho
    Da Costa, Larissa Maria
    Dias, Yasmin
    Goncalves Celso, Davi Said
    Dos Santos, Marcela Bonalumi
    De Souza, Mariana
    Vilbert, Maysa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials
    Liu, Shuyu
    Zhang, Dan
    Wu, Jiarui
    Wang, Kaihuan
    Zhao, Yi
    Ni, Mengwei
    Meng, Ziqi
    Zhang, Xiaomeng
    INTEGRATIVE CANCER THERAPIES, 2018, 18
  • [30] Adjuvant Denosumab treatment in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
    Mastrantoni, Luca
    Garufi, Giovanna
    Di Monte, Elena
    Maliziola, Noemi
    Pasqualoni, Mariangela
    Pontolillo, Letizia
    Pannunzio, Sergio
    Cannizzaro, Maria Chiara
    Di Bello, Armando
    Fabi, Alessandra
    Palazzo, Antonella
    Bria, Emilio
    Tortora, Giampaolo
    Orlandi, Armando
    CANCER RESEARCH, 2023, 83 (05)
12345